Global Vascular Embolization Devices Market 2022-2026
Technavio has been monitoring the vascular embolization devices market and it is poised to grow by $ 569.63 mn during 2022-2026, accelerating at a CAGR of 5.83% during the forecast period. Our report on the vascular embolization devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of vascular diseases, the rising number of new product launches, and a growing number of M and A activities.
The vascular embolization devices market analysis includes product segment and geographic landscape.
Technavio's vascular embolization devices market is segmented as below:
By Product
- Coiling devices
- Non-coiling devices
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing number of strategic alliances as one of the prime reasons driving the vascular embolization devices market growth during the next few years. Also, funding for start-up companies from venture capitalists and government organizations and innovation in embolization products and procedures will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the vascular embolization devices market covers the following areas:
- Vascular embolization devices market sizing
- Vascular embolization devices market forecast
- Vascular embolization devices market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vascular embolization devices market vendors that include Abbott Laboratories, Acandis GmbH, B. Braun SE, BALT Group, Boston Scientific Corp., Braile Biomedica, Cook Group Inc., Eisai Co. Ltd., Embolx Inc., Guerbet, Johnson and Johnson, Kaneka Medix Corp., Medtronic Plc, Merit Medical Systems Inc., Penumbra Inc., phenoxy GmbH, Shape Memory Medical Inc., Spartan Micro Inc., Stryker Corp., and Terumo Corp. Also, the vascular embolization devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.